Literature DB >> 14727051

Direct organogenesis of Mandevilla illustris (Vell) Woodson and effects of its aqueous extract on the enzymatic and toxic activities of Crotalus durissus terrificus snake venom.

R Biondo1, A M Soares, B W Bertoni, S C França, A M S Pereira.   

Abstract

In order to produce explants of Mandevilla illustris (Vell) Woodson for the "Cerrado in vitro", the Germplasm Bank of UNAERP, we carried out a micropropagation protocol using MS or MS/3 medium supplemented with different concentrations of 6-benzyladeninepurine (BA), Zeatin or 2-isopentenyladenine for nodal segment growth, and alpha-naphthaleneacetic acid, indole-3-butyric acid (IBA) or 1,4 dithiothreitol for rooting. For nodal segments, all the cytokinins tested yielded similar results. However, 2.22 micro M BA is more economical to use. MS/3 medium supplemented with 0.49 micro M IBA was the most appropriate medium for rooting, resulting in 29% rooted explants. The crude aqueous extract from the subterranean system (SS) of M. illustris was assayed for its inhibitory action on the enzymatic activity of Crotalus durissus terrificus snake venom, isolated basic phospholipase A2 (CB) and crotoxin. It totally inhibited the phospholipase activity of crude Cdt venom and CB toxin and inhibited the phospholipase activity of crotoxin by 49%. The toxic action of both the crude venom and crotoxin was partially inhibited-there was a prolonged survival time and a 40.0% decrease in lethality.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14727051     DOI: 10.1007/s00299-003-0722-6

Source DB:  PubMed          Journal:  Plant Cell Rep        ISSN: 0721-7714            Impact factor:   4.570


  14 in total

Review 1.  Plants with a reputation against snakebite.

Authors:  W Martz
Journal:  Toxicon       Date:  1992-10       Impact factor: 3.033

2.  Neurotoxic and myotoxic effects of crotalus phospholipase A and its complex with crotapotin.

Authors:  H Breithaupt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

3.  An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica.

Authors:  J M Gutiérrez; C Avila; E Rojas; L Cerdas
Journal:  Toxicon       Date:  1988       Impact factor: 3.033

4.  Inhibition of the lethal and myotoxic activities of Crotalus durissus terrificus venom by Tabernaemontana catharinensis: identification of one of the active components.

Authors:  M de F Batina; A C Cintra; E L Veronese; M A Lavrador; J R Giglio; P S Pereira; D A Dias; S C França; S V Sampaio
Journal:  Planta Med       Date:  2000-06       Impact factor: 3.352

5.  Effects of chemical modifications of crotoxin B, the phospholipase A(2) subunit of crotoxin from Crotalus durissus terrificus snake venom, on its enzymatic and pharmacological activities.

Authors:  A M Soares; A C Mancin; A L Cecchini; E C Arantes; S C França; J M Gutiérrez; J R Giglio
Journal:  Int J Biochem Cell Biol       Date:  2001-09       Impact factor: 5.085

6.  Effects of aqueous extract of Casearia sylvestris (Flacourtiaceae) on actions of snake and bee venoms and on activity of phospholipases A2.

Authors:  M H Borges; A M Soares; V M Rodrigues; S H Andrião-Escarso; H Diniz; A Hamaguchi; A Quintero; S Lizano; J M Gutiérrez; J R Giglio; M I Homsi-Brandeburgo
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2000-09       Impact factor: 2.231

7.  Ability of wedelolactone, heparin, and para-bromophenacyl bromide to antagonize the myotoxic effects of two crotaline venoms and their PLA2 myotoxins.

Authors:  P A Melo; C L Ownby
Journal:  Toxicon       Date:  1999-01       Impact factor: 3.033

8.  Inhibition of the myotoxic and hemorrhagic activities of crotalid venoms by Eclipta prostrata (Asteraceae) extracts and constituents.

Authors:  P A Melo; M C do Nascimento; W B Mors; G Suarez-Kurtz
Journal:  Toxicon       Date:  1994-05       Impact factor: 3.033

9.  Tissue, cell culture and micropropagation of Mandevilla velutina, a natural source of a bradykinin antagonist.

Authors:  W Handro; E I Floh; C M Ferreira; M P Guerra
Journal:  Plant Cell Rep       Date:  1988-12       Impact factor: 4.570

10.  Inhibition of enzymatic and pharmacological activities of some snake venoms and toxins by Mandevilla velutina (Apocynaceae) aqueous extract.

Authors:  Ronaldo Biondo; Ana Maria S Pereira; Silvana Marcussi; Paulo S Pereira; Suzelei C França; Andreimar M Soares
Journal:  Biochimie       Date:  2003-10       Impact factor: 4.079

View more
  5 in total

1.  Crystallization and preliminary X-ray crystallographic studies of a Lys49-phospholipase A2 homologue from Bothrops pirajai venom complexed with rosmarinic acid.

Authors:  Juliana I dos Santos; Norival A Santos-Filho; Andreimar M Soares; Marcos R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-05-27

2.  Structural and functional studies of a bothropic myotoxin complexed to rosmarinic acid: new insights into Lys49-PLA₂ inhibition.

Authors:  Juliana I Dos Santos; Fábio F Cardoso; Andreimar M Soares; Maeli Dal Pai Silva; Márcia Gallacci; Marcos R M Fontes
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

Review 3.  Snake venom PLA2s inhibitors isolated from Brazilian plants: synthetic and natural molecules.

Authors:  B M A Carvalho; J D L Santos; B M Xavier; J R Almeida; L M Resende; W Martins; S Marcussi; S Marangoni; R G Stábeli; L A Calderon; A M Soares; S L Da Silva; D P Marchi-Salvador
Journal:  Biomed Res Int       Date:  2013-09-22       Impact factor: 3.411

4.  A randomized ethnomedicinal survey of snakebite treatment in southwestern parts of Bangladesh.

Authors:  Md Nazmul Hasan; Nur Kabidul Azam; Md Nasir Ahmed; Akinori Hirashima
Journal:  J Tradit Complement Med       Date:  2015-04-21

Review 5.  Medicinal Plants for the Treatment of Local Tissue Damage Induced by Snake Venoms: An Overview from Traditional Use to Pharmacological Evidence.

Authors:  Juliana Félix-Silva; Arnóbio Antônio Silva-Junior; Silvana Maria Zucolotto; Matheus de Freitas Fernandes-Pedrosa
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-21       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.